1. 1 2011 Parkinson Disease Activity Final Metrics August 28, 2012

2. 2 Teva-Supported PD Activity on Medscape Education Neurology

3. 3 PhysiciansAllied Health Activity Launch Date Learners CME/ CE Test Takers NeurosPCPsTotal MDsNursesPA/ NPTotal HCPs Disease Modification in Parkinson Disease: Are We There Yet? www.medscape.org/viewarticle/745018 6/24/11 9,3001,5214,2471,904 7,548 (252% of guarantee) 2542531,680 Through July 31, 2011 Teva-Supported PD Activity on Medscape Education Neurology Participation Through July 31, 2012

4. 4 Teva-Supported PD Activity on Medscape Education Neurology High Satisfaction Through July 31, 2012

5. 5 Teva-Supported PD Activity on Medscape Education Neurology Improved Performance Through July 31, 2012

6. 6 Teva-Supported PD Activity on Medscape Education Neurology Perceived Barriers to Improved Performance Through July 31, 2012

7. 7 Does Effective Online Education Make a Difference? Estimated Impact of the Teva-Supported PD Activity on Patient Care FactorsProjected ImpactSource/Calculation Estimated number of Americans suffering from PD500,000 National Institute of Neurological Diseases and Stroke/NIH http://www.ninds.nih.gov/disorders/parkinsons_disease/parkinso ns_disease_backgrounder.htm Estimated number of neurologists13,366AMA database Average number of potential PD patients seen per clinician (estimated)37Total patients with MS/estimated neurologists Neurologist learners/interactions for activity (through 7/31/12)4,247Medscape metrics report An average of 63% of neurologist learners planned to make changes to their practice (modify their treatment plans and/or change their screening/prevention practice after participating in the activity), reflecting expected impact of the activity 2,675Medscape metrics report 79% of neurologist learners are very/somewhat committed to making changes 2,113Medscape metrics report The number of patients with PC expected to have improved outcomes as a direct result of the Disease Modification in Parkinson Disease: Are We There Yet? Activity 78,208 (~16% of all patients with PD) # of neurologist learners who are expecting to change their practice and are committed to making a change (2,113) x the average number patients with PD per neurologist (37) Through July 31, 2012

8. 8 Teva-Supported PD Activity on Medscape Education Neurology Cost Effective Education ReachCost Per… Readers9,300 $8.87 per clinician reader Neurologist Readers 4,247$17.07 Patients Estimated 78,208 ~$1.05 per patient with improved outcomes Through July 31, 2012

9. 9 Overall PD Activity Impact Summary of Impact vs. Educational Goals Educational GoalCombined Impact Strong reach to target audience membersOver 9,300 clinician interactions to date Strong impact on knowledge and behavior Making a strong impact on their knowledge and behavior An average of 63% of clinician readers planned to modify their treatment plans and/or change their screening/prevention practice after participating in the activity An average of 79% of readers are very/somewhat committed to making changes Estimated number of patients with improved outcomes as a result of clinician education Over 78,208 patients, 16% of all patients with PD Be cost-effective Extremely cost-effective $8.87 per clinician reader $17.07 per neurologist reader ~$1.05 per patient with improved outcomes Through July 31, 2012